Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-28 @ 6:08 PM
Study NCT ID:
NCT00949650
Status:
COMPLETED
Last Update Posted:
2018-04-06
First Post:
2009-07-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2012-02-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-16
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-29
First Submit QC Date:
None
Study First Post Date:
2009-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-08-08
Results First Submit QC Date:
None
Results First Post Date:
2013-11-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-09
Last Update Post Date:
2018-04-06
Last Update Post Date Type:
ACTUAL